As the second most frequently mutated chromatin modifying gene in B-cell lymphoma, the CREBBP gene is recurrently mutated in 65% of FL patients and 16% of DLBCL (Pasqualucci et al., 2011a; Green, 2018). This evidence concerns the gene CREBBP and B-cell non-Hodgkin lymphoma.